Literature DB >> 2109426

RS-61443 allows islet allografting and specific tolerance induction in adult mice.

L Hao1, K J Lafferty, A C Allison, E M Eugui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2109426

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

Review 1.  Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols.

Authors:  R Indudhara; R B Khauli
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 2.  The design and development of an immunosuppressive drug, mycophenolate mofetil.

Authors:  A C Allison; E M Eugui
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Effects of mycophenolate mofetil vs cyclosporine administration on graft survival and function after islet allotransplantation in diabetic rats.

Authors:  Constantin Fotiadis; Paraskevi Xekouki; Apostolos E Papalois; Pantelis T Antonakis; Ioannis Sfiniadakis; Dimitrios Flogeras; Eleutheria Karampela; George Zografos
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

Review 4.  Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.

Authors:  W D Simmons; S C Rayhill; H W Sollinger
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

Review 5.  Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.

Authors:  B Fulton; A Markham
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

Review 6.  Post-transplant diabetes mellitus. The role of immunosuppression.

Authors:  R M Jindal; R A Sidner; M L Milgrom
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

7.  Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center.

Authors:  M H Deierhoi; R S Kauffman; S L Hudson; W H Barber; J J Curtis; B A Julian; R S Gaston; D A Laskow; A G Diethelm
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

8.  RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection.

Authors:  H W Sollinger; F O Belzer; M H Deierhoi; A G Diethelm; T A Gonwa; R S Kauffman; G B Klintmalm; S V McDiarmid; J Roberts; J T Rosenthal
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

9.  Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.

Authors:  T Furlong; P Martin; M E D Flowers; F Carnevale-Schianca; R Yatscoff; T Chauncey; F R Appelbaum; H J Deeg; K Doney; R Witherspoon; B Storer; K M Sullivan; R Storb; R A Nash
Journal:  Bone Marrow Transplant       Date:  2009-04-20       Impact factor: 5.483
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.